4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-006255
Options or other derivatives
- CEO, CFO acquired 2,011,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Finley John David CEO, CFO | 2026-02-09 | Grant or award · Restricted Stock Units | +2,011,000 | 2,011,000 | D | ||
Loading xslF345X05/ownership.xml…